Multiple sclerosis (MS)
253 results
101 - 200
Psychological interventions for multiple sclerosis
Interferon beta for secondary progressive multiple sclerosis - Respiratory muscle training for multiple sclerosis
- Aminopyridines for symptomatic treatment in multiple sclerosis
- Amantadine for fatigue in multiple sclerosis
- Azathioprine for multiple sclerosis
- Dietary interventions for multiple sclerosis‐related outcomes
- Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis
- Pharmacologic treatment of depression in multiple sclerosis
- Interferon in relapsing‐remitting multiple sclerosis
- Corticosteroids for the long-term treatment in multiple sclerosis: Cochrane systematic review
- Interferon Beta for Primary Progressive Multiple Sclerosis
- Cyclophosphamide for multiple sclerosis
OB outcomes for those with MS and epilepsy similar to general population; diabetics worse- Carnitine for fatigue in multiple sclerosis
- Information provision for people with multiple sclerosis
- Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
- Conservative interventions for urinary or faecal incontinence, or both, in adults with multiple sclerosis
- Treatment for ataxia in multiple sclerosis
- Palliative care interventions for people with multiple sclerosis
- Pharmacological treatment for memory disorder in multiple sclerosis: Cochrane systematic review
- Alemtuzumab more effective than interferon for multiple sclerosis
- Immunomodulators and immunosuppressants for multiple sclerosis: a network meta‐analysis
- Lumbar puncture
- Anticholinergics for urinary symptoms in multiple sclerosis: Cochrane systematic review
- Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis
- Teriflunomide for multiple sclerosis
- Exercise therapy for fatigue in multiple sclerosis
- List of abbreviations
- Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis
- Corticosteroids or ACTH for acute exacerbations in multiple sclerosis: Cochrane systematic review
- Vitamin D for the management of multiple sclerosis
- Impaired vision
- Azathioprine for people with multiple sclerosis
- Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis
- Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis: Cochrane systematic review
- Teriflunomide for multiple sclerosis
- Mitoxantrone for multiple sclerosis
- Rituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review
- Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
- Episodic attacks of flushing
- Multidisciplinary rehabilitation for adults with multiple sclerosis
- Telerehabilitation for persons with multiple sclerosis
- Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews
- Exercise therapy for multiple sclerosis
- Laquinimod for multiple sclerosis: Cochrane systematic review
- Amantadine for fatigue in multiple sclerosis
- Fingolimod for relapsing‐remitting multiple sclerosis
- Interventions for preventing falls in people with multiple sclerosis
- alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis
- Mycophenolate mofetil for relapsing-remitting multiple sclerosis: Cochrane systematic review
- Alemtuzumab for multiple sclerosis
- Non-pharmacological interventions for spasticity in multiple sclerosis
- Daclizumab for relapsing remitting multiple sclerosis
- Mitoxantrone for multiple sclerosis: Cochrane systematic review
- Natalizumab for relapsing remitting multiple sclerosis: Cochrane systematic review
- Glatiramer acetate for multiple sclerosis
- Glatiramer acetate for multiple sclerosis
- Obstipation in the adult
- Rituximab for people with multiple sclerosis
- Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
- Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
- Interferon beta for secondary progressive multiple sclerosis
- Non pharmacological interventions for spasticity in multiple sclerosis: Cochrane systematic review
- Corticosteroids for the long-term treatment in multiple sclerosis
- Memory rehabilitation for people with multiple sclerosis
- Multidisciplinary rehabilitation for adults with multiple sclerosis
- Siponimod for multiple sclerosis
- Dyspnoea
- Alemtuzumab for multiple sclerosis
- Diseases of the spinal cord
- Dimethyl fumarate for multiple sclerosis: Cochrane systematic review
- Neuropsychological rehabilitation for multiple sclerosis
- Pharmacologic treatment for memory disorder in multiple sclerosis
- Eye symptoms and signs of systemic diseases
- Fatigue